INS and Hyperglycemia: It ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of phosphoenolpyruvate carboxykinase, GLUT4 [171], and AKT1 and AKT3 and inhibiting DNA glycation [172].